US 11066405
Bicyclic compounds and their use in the treatment of cancer
granted A61PA61P35/00
Quick answer
US patent 11066405 (Bicyclic compounds and their use in the treatment of cancer) held by TEMPEST THERAPEUTICS, INC. expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEMPEST THERAPEUTICS, INC.
- Grant date
- Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P35/00